Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study
about
Antimicrobial resistance-a threat to the world's sustainable developmentHIV-1 drug resistance and resistance testing.Sensitive Next-Generation Sequencing Method Reveals Deep Genetic Diversity of HIV-1 in the Democratic Republic of the Congo.Appraising Viral Load Thresholds and Adherence Support Recommendations in the World Health Organization Guidelines for Detection and Management of Virologic Failure.Transmission fitness of drug-resistant HIV revealed in a surveillance system transmission networkRapid accumulation of HIV-1 thymidine analogue mutations and phenotypic impact following prolonged viral failure on zidovudine-based first-line ART in sub-Saharan Africa.Cross-sectional study of virological failure and multinucleoside reverse transcriptase inhibitor resistance at 12 months of antiretroviral therapy in Western IndiaMutational Correlates of Virological Failure in Individuals Receiving a WHO-Recommended Tenofovir-Containing First-Line Regimen: An International Collaboration.Occult HIV-1 drug resistance to thymidine analogues following failure of first-line tenofovir combined with a cytosine analogue and nevirapine or efavirenz in sub Saharan Africa: a retrospective multi-centre cohort study.HIV Drug Resistance Mutations in Non-B Subtypes After Prolonged Virological Failure on NNRTI-Based First-Line Regimens in Sub-Saharan Africa.Virological Outcomes of Second-line Protease Inhibitor-Based Treatment for Human Immunodeficiency Virus Type 1 in a High-Prevalence Rural South African Setting: A Competing-Risks Prospective Cohort Analysis.Modeling the Mechanisms by Which HIV-Associated Immunosuppression Influences HPV Persistence at the Oral Mucosa.An analysis of drug resistance among people living with HIV/AIDS in Shanghai, ChinaEnhanced antibody-mediated neutralization of HIV-1 variants that are resistant to fusion inhibitors.No Evidence That HIV-1 Subtype C Infection Compromises the Efficacy of Tenofovir-Containing Regimens: Cohort Study in the United Kingdom.Wide variation in susceptibility of transmitted/founder HIV-1 subtype C Isolates to protease inhibitors and association with in vitro replication efficiency.Development of HIV drug resistance and therapeutic failure in children and adolescents in rural Tanzania: an emerging public health concern.From policy to action: how to operationalize the treatment for all agendaSignificant rates of risky sexual behaviours among HIV-infected patients failing first-line ART: A sub-study of the Europe-Africa Research Network for the Evaluation of Second-line Therapy trial.Advanced HIV disease in Botswana following successful antiretroviral therapy rollout: Incidence of and temporal trends in cryptococcal meningitis.Accumulation of HIV-1 drug resistance after continued virological failure on first-line ART in adults and children in sub-Saharan Africa.High level of HIV-1 drug resistance mutations in patients with unsuppressed viral loads in rural northern South Africa.The value of point-of-care CD4+ and laboratory viral load in tailoring antiretroviral therapy monitoring strategies to resource limitations.Design, synthesis and antiviral evaluation of novel heteroarylcarbothioamide derivatives as dual inhibitors of HIV-1 reverse transcriptase-associated RNase H and RDDP functions.Collaborative update of a rule-based expert system for HIV-1 genotypic resistance test interpretation.Epidemiological trends of HIV-1 infection in blood donors from Catalonia, Spain (2005-2014).Prevalence of HIV Antiretroviral Drug Resistance and Its Impacts on HIV-1 Virological Failures in Jiangsu, China: A Cross-Sectional Study.Rates of virological suppression and drug resistance in adult HIV-1-positive patients attending primary healthcare facilities in KwaZulu-Natal, South Africa.Human Immunodeficiency Virus Type 1 Drug Resistance Mutations Update.HIV-1 Subtype C, Tenofovir, and the Relationship With Treatment Failure and Drug ResistanceEditorial Commentary: HIV Is Putting Up Less Resistance.Long-term Outcome of Antiretroviral Treatment in Patients With and Without Concomitant Tuberculosis Receiving Health Center-Based Care-Results From a Prospective Cohort Study.Upward trends of acquired drug resistances in Ethiopian HIV-1C isolates: A decade longitudinal study.Expansion of Viral Load Testing and the Potential Impact on HIV Drug Resistance.HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review and meta-regression analysis.High risk exposure to HIV among sexually active individuals who tested negative on rapid HIV Tests in the Tshwane District of South Africa-The importance of behavioural prevention measures.Evaluation of the fusion inhibitor P3 peptide as a potential microbicide to prevent HIV transmission in women.Patterns of emergent resistance-associated mutations after initiation of non-nucleoside reverse-transcriptase inhibitor-containing antiretroviral regimens in Taiwan: a multicenter cohort study.An association between K65R and HIV-1 subtype C viruses in patients treated with multiple NRTIs.Drug resistance outcomes of long-term ART with tenofovir disoproxil fumarate in the absence of virological monitoring
P2860
Q30061997-F4A72137-9669-4461-B321-643972A8F694Q30245693-D1E98AEC-1224-413A-BF1C-703D97DDA679Q30397336-5F560725-7514-407F-A303-CFC0C8A16835Q30492033-879FF1D4-B0FB-43E8-83BE-36CF5B5AD647Q33589187-6C43834C-45A2-42AF-86DD-650C215867B5Q33589766-14925E55-EC9E-4ACD-9EB2-D9C9AB58D4A5Q33595427-638A2F61-39F6-46EF-BC60-45CC1E1E05C2Q33603586-AF3DCE8D-49CB-493D-94F6-1AB07CB5681EQ33647567-89658A99-94A0-4A40-8E21-32B1638FBD7DQ33669836-A081CCD0-FD30-497D-9BB4-CCCB42F00E93Q33712438-B881E540-A1C9-4FDF-87CD-14ADD053015FQ36242558-0A736970-C318-4ECB-9C72-A29BB5ED93F3Q36277181-42E78F64-DE2D-4327-A55D-7D0ED26D82B3Q37286064-EF3EA09E-D07E-483B-83D4-A75B7AB5E03FQ37365060-F30598A7-24BD-47A0-805E-83F9A9D3196FQ37454209-AECFCC0A-273F-4A1D-AAF4-FA1C5D440E9EQ37461250-38133C58-4D9C-49A5-832F-03F89AB011F6Q37512416-0BC6F384-75E0-4692-AE9C-DAC0C9DA98C4Q38621767-C186ACE6-8151-4DD0-AEE3-0B0637355577Q38785746-B08EC62D-5A0E-4E20-8775-6733AF77C670Q38854117-35DB3F5D-90C5-4582-A0A4-B46E7BDC6013Q38996079-C43D64C5-2BCA-48E6-B941-383E545EE233Q40041518-2640A58F-B8B8-4307-88C5-59DF68922051Q40062788-90950227-6794-40BC-BBB2-47A659124730Q40104085-B172BE45-E07B-4C82-AAD9-6ADB4F10AA61Q40133561-6E00526B-59C0-4A0D-8CD0-BCE4E1E4BE35Q40468293-8CDBB506-E45A-42F0-B3E3-BFF0B8275A2DQ41923640-4BE982F4-76D2-4DAB-B5C5-6995E70CA73DQ41926589-BC57B11F-36A5-4729-A24B-C94346C33522Q42380140-3E5991AA-8C40-4116-9745-AB46F68E1CF5Q46105162-F9925452-31DB-4E1F-B978-144F305ADE97Q46634665-AB6AD21D-5DDE-4F78-9F16-AA5388E19C46Q46662332-693D3A75-A566-41FC-BCC0-8F062B94336FQ47365647-D3C702BC-605E-4F92-9584-5553F5CFA51BQ47378001-D85D355A-11A0-4455-A76F-179A4BF39CAAQ47546880-54C3753A-8D12-4069-A105-3D334E486C9EQ52580522-A1401D56-2C3B-41EC-89BA-ABC1866F1B17Q55333264-327B9528-D54A-4C75-848F-3A0BD519F97CQ55340159-6AF2D442-D90E-4DD7-9E5B-D112CD69B112Q57500517-D86F3BFC-B91D-4D8C-8B2C-230B160367A5
P2860
Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study
description
2016 nî lūn-bûn
@nan
2016 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Global epidemiology of drug re ...... tre retrospective cohort study
@ast
Global epidemiology of drug re ...... tre retrospective cohort study
@en
type
label
Global epidemiology of drug re ...... tre retrospective cohort study
@ast
Global epidemiology of drug re ...... tre retrospective cohort study
@en
prefLabel
Global epidemiology of drug re ...... tre retrospective cohort study
@ast
Global epidemiology of drug re ...... tre retrospective cohort study
@en
P2860
P921
P1476
Global epidemiology of drug re ...... tre retrospective cohort study
@en
P2093
TenoRes Study Group
P2860
P304
P356
10.1016/S1473-3099(15)00536-8
P577
2016-01-28T00:00:00Z